Daniel Arias's Stock Ratings

Stifel Analyst

Daniel Arias is an analyst at Stifel. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 02/27/2025

Overall Average Return

12.4%

Smart Score

67%

Overall Average Return Percentile

66th

Number of Ratings

157
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

What's Going On With Cancer Diagnostic Firm Guardant Health On Friday?
Guardant Health beat Q4 estimates with a smaller EPS loss and strong revenue growth. Analysts raised price targets, citing momentum and solid financials.
Life Science Company 10x Genomics Struggles With Profitability, Analyst Says 2025 Guidance Bakes In NIH Funding Uncertainties
10x Genomics reported a Q4 EPS loss of $(0.40), missing estimates, while revenue declined 10% year over year. Analysts lowered price targets amid profitability concerns.
Beyond The Numbers: 5 Analysts Discuss Avantor Stock
8 Analysts Have This To Say About Tempus AI
Forecasting The Future: 19 Analyst Projections For Exact Sciences
Beyond The Numbers: 6 Analysts Discuss Tempus AI Stock
What Analysts Are Saying About Waters Stock
14 Analysts Have This To Say About Danaher
What 19 Analyst Ratings Have To Say About Exact Sciences
Nvidia To Rally More Than 18%? Here Are 10 Top Analyst Forecasts For Monday
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved